Related Experiment Video
Updated: Jul 2, 2025

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies
Juanjuan Shang1, Shunfeng Hu2, Xin Wang3,4,5,6,7
1Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, 250021, Shandong, China.
Natural killer (NK) cells are crucial for immune defense. Therapies enhancing NK cell function show promise for treating hematologic malignancies, but optimizing their long-term efficacy requires further research.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Natural killer (NK) cells are part of the innate immune system, vital for immunosurveillance and host defense.
- Tumor microenvironments can impair NK cell function, necessitating strategies to overcome this dysfunction.
- NK cell-based therapies offer advantages over T cell therapies, including reduced graft-versus-host disease and neurotoxicity.
Purpose of the Study:
- To review the role of NK cells in tumor development.
- To highlight current advancements in NK cell-targeted therapies for hematologic malignancies.
- To identify challenges and future directions for enhancing NK cell maintenance and function in cancer treatment.
Main Methods:
- Systematic review of existing literature on NK cell biology and immunotherapy.
- Analysis of therapeutic strategies including immune checkpoint blockade (ICB), chimeric antigen receptor NK (CAR-NK) cells, and bispecific/trispecific killer cell engagers (BiKE/TriKE).
- Evaluation of clinical data and research findings on NK cell therapy efficacy and challenges.
Main Results:
- NK cells play a significant role in controlling tumor progression.
- Emerging NK cell-based therapies demonstrate promising efficacy and favorable safety profiles in clinical settings.
- Current therapeutic strategies like ICB, CAR-NK, and BiKE/TriKE are advancing NK cell immunotherapy.
Conclusions:
- NK cell-targeted therapies represent a promising frontier in treating hematologic malignancies.
- Further research is needed to optimize NK cell function and maintenance for improved patient response rates and durable remission.
- Addressing the complexities of the tumor microenvironment is key to unlocking the full potential of NK cell immunotherapy.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Regulation of Hematopoietic Stem Cells

